ExpansionJul 1, 2026, 05:26 PM
Avalyn Pharma Expands Boston Office by 4,934 Sq Ft
AI Summary
Avalyn Pharma Inc. entered into a First Amendment to its Sublease Agreement with CRISPR Therapeutics, Inc., expanding its leased premises at 105 West First Street, Boston. The company will increase its office space from approximately 8,774 rentable square feet to 13,708 rentable square feet, adding 4,934 square feet. This expansion will result in an increase of approximately $924,000 in future minimum lease payments over the remaining lease term.
Key Highlights
- Expanded Boston office space by 4,934 rentable square feet.
- Total leased area increased from 8,774 to 13,708 rentable square feet.
- Future minimum lease payments to increase by approximately $924,000.
- Expansion Premises Commencement Date is June 29, 2026.
- Sublease term for expanded space expires January 31, 2029.
Price Impact
More from AVLN